BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee RM, Cardona K, Russell MC. Historical perspective: Two decades of progress in treating metastatic colorectal cancer. J Surg Oncol 2019;119:549-63. [PMID: 30806493 DOI: 10.1002/jso.25431] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Tonello M, Baratti D, Sammartino P, Di Giorgio A, Robella M, Sassaroli C, Framarini M, Valle M, Macrì A, Graziosi L, Coccolini F, Lippolis PV, Roberta G, Deraco M, Biacchi D, Santullo F, Vaira M, Di Lauro K, D'Acapito F, Carboni F, Giuffrè G, Donini A, Fugazzola P, Faviana P, Lorena S, Scapinello A, Del Bianco P, Sommariva A. Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol 2021. [PMID: 34783946 DOI: 10.1245/s10434-021-11045-3] [Reference Citation Analysis]
2 Melstrom LG, Warner SG, Wong P, Sun V, Raoof M, Singh G, Chavin KD, Fong Y, Adam R, Hugh TJ. Management of disappearing colorectal liver metastases: an international survey. HPB 2021;23:506-11. [DOI: 10.1016/j.hpb.2020.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Huang X, Yang Z, Xie Q, Zhang Z, Zhang H, Ma J. Natural products for treating colorectal cancer: A mechanistic review. Biomedicine & Pharmacotherapy 2019;117:109142. [DOI: 10.1016/j.biopha.2019.109142] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
4 Melstrom LG, Tzeng CD. Metastatic colorectal cancer: The reality of the present and the optimism of the future. J Surg Oncol 2019;119:547-8. [PMID: 30806484 DOI: 10.1002/jso.25427] [Reference Citation Analysis]
5 Nie X, Liu H, Liu L, Wang YD, Chen WD. Emerging Roles of Wnt Ligands in Human Colorectal Cancer. Front Oncol 2020;10:1341. [PMID: 32923386 DOI: 10.3389/fonc.2020.01341] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
6 Jiang C, Liu Y, Wen S, Xu C, Gu L. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma. Pharmacol Res 2021;169:105644. [PMID: 33940186 DOI: 10.1016/j.phrs.2021.105644] [Reference Citation Analysis]
7 Ruan Z, Deng H, Liang M, Xu Z, Lai M, Ren H, Deng X, Su X. Downregulation of long non-coding RNA MAFG-AS1 represses tumorigenesis of colorectal cancer cells through the microRNA-149-3p-dependent inhibition of HOXB8. Cancer Cell Int 2020;20:511. [PMID: 33093810 DOI: 10.1186/s12935-020-01485-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Sun R, Gu J, Chang X, Liu F, Liang Y, Yang X, Liang L, Tang D. Metabonomics study on orthotopic transplantion mice model of colon cancer treated with Astragalus membranaceus-Curcuma wenyujin in different proportions via UPLC-Q-TOF/MS. J Pharm Biomed Anal 2021;193:113708. [PMID: 33129117 DOI: 10.1016/j.jpba.2020.113708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Luo T, Wang Y, Shan X, Bai Y, Huang C, Li G, Wang H. Nomogram based on homogeneous and heterogeneous associated factors for predicting distant metastases in patients with colorectal cancer. World J Surg Oncol 2021;19:30. [PMID: 33504354 DOI: 10.1186/s12957-021-02140-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Chiang CT, Lau R, Ghaffarizadeh A, Brovold M, Vyas D, Juárez EF, Atala A, Agus DB, Soker S, Macklin P, Ruderman D, Mumenthaler SM. High-throughput microscopy reveals the impact of multifactorial environmental perturbations on colorectal cancer cell growth. Gigascience 2021;10:giab026. [PMID: 33871006 DOI: 10.1093/gigascience/giab026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wu Y, Zhou Y, Gao H, Wang Y, Cheng Q, Jian S, Ding Q, Gu W, Yao Y, Ma J, Wu W, Li Y, Tong X, Song X, Ma S. LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism. Oxid Med Cell Longev 2021;2021:9979707. [PMID: 35069968 DOI: 10.1155/2021/9979707] [Reference Citation Analysis]
12 Gu L, Liu Y, Jiang C, Sun L, Zhou H. Identification and clinical validation of metastasis-associated biomarkers based on large-scale samples in colon-adenocarcinoma. Pharmacol Res 2020;160:105087. [PMID: 32683036 DOI: 10.1016/j.phrs.2020.105087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 He X, Ma J, Zhang M, Cui J, Yang H. Long Non-Coding RNA SNHG16 Activates USP22 Expression to Promote Colorectal Cancer Progression by Sponging miR-132-3p. Onco Targets Ther 2020;13:4283-94. [PMID: 32547062 DOI: 10.2147/OTT.S244778] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
14 Ding X, Chen T, Shi Q, Nan P, Wang X, Xie D, Li J. INTS6 promotes colorectal cancer progression by activating of AKT and ERK signaling. Exp Cell Res 2021;407:112826. [PMID: 34508742 DOI: 10.1016/j.yexcr.2021.112826] [Reference Citation Analysis]
15 Liu Z, Xu Y, Xu G, Baklaushev VP, Chekhonin VP, Peltzer K, Ma W, Wang X, Wang G, Zhang C. Nomogram for predicting overall survival in colorectal cancer with distant metastasis. BMC Gastroenterol 2021;21:103. [PMID: 33663400 DOI: 10.1186/s12876-021-01692-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wei J, Lin Y, Wang Z, Liu Y, Guo W. Circ_0006174 Accelerates Colorectal Cancer Progression Through Regulating miR-138-5p/MACC1 Axis. Cancer Manag Res 2021;13:1673-86. [PMID: 33628056 DOI: 10.2147/CMAR.S295833] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Chen Y, Zhao J. Identification of an Immune Gene Signature Based on Tumor Microenvironment Characteristics in Colon Adenocarcinoma. Cell Transplant 2021;30:9636897211001314. [PMID: 33787354 DOI: 10.1177/09636897211001314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ernani L, Fernandes EDSM, Martino RBD, Coelho FF, Mello FPTD, Andrade R, Pimentel LS, Haddad LBDP, Herman P, Andraus W, D’albuquerque LAC. PROTOCOLO DE TRANSPLANTE HEPÁTICO PARA METÁSTASE COLORRETAL IRRESSECÁVEL. ABCD, arq bras cir dig 2021;34:e1625. [DOI: 10.1590/0102-672020210002e1625] [Reference Citation Analysis]
19 Wong CH, Sundberg T, Chung VC, Voiss P, Cramer H. Complementary medicine use in US adults with a history of colorectal cancer: a nationally representative survey. Support Care Cancer 2021;29:271-8. [PMID: 32358777 DOI: 10.1007/s00520-020-05494-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]